We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
January 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
RECOMBINANT FELINE LEUKEMIA VIRUS VACCINE CONTAINING OPTIMIZED FELINE LEUKEMIA VIRUS ENVELOPE GENE
VACUUM -ASSISTED PRESERVATION OF BIOLOGICAL PRODUCTS, IN PARTICULAR OF VACCINES
COMPOSITIONS AND METHODS FOR TREATING ANDROGEN RECEPTOR DEPENDENT DISORDERS INCLUDING CANCERS